Controlled Equity OfferingSM Sales AgreementCidara Therapeutics, Inc. • May 20th, 2016 • Biological products, (no disgnostic substances) • New York
Company FiledMay 20th, 2016 Industry JurisdictionCidara Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
CIDARA THERAPEUTICS, INC. FORM OF COMMON STOCK WARRANT AGREEMENTCommon Stock Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 20th, 2016 Company Industry JurisdictionThis Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Cidara Therapeutics, Inc. and _____________, As Warrant Agent Form Of Preferred Stock Warrant Agreement Dated As Of __________Preferred Stock Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 20th, 2016 Company Industry JurisdictionThis Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Cidara Therapeutics, Inc. and _____________, As Warrant Agent Form Of Debt Securities Warrant Agreement Dated As Of __________Securities Warrant Agreement • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 20th, 2016 Company Industry JurisdictionThis Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CIDARA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt SecuritiesIndenture • May 20th, 2016 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 20th, 2016 Company Industry Jurisdiction